 | |
| Company type | Subsidiary |
|---|---|
| Industry | Pharmaceutical industry |
| Founded | 1921 |
| Headquarters | Zagreb, Croatia |
Key people | Mihael Furjan ( CEO) |
| Products | Generic drugs |
| Revenue | $1.174 billion (2005) |
| $0.336 billion (2005) | |
Number of employees | 1,700 |
| Parent | Teva Pharmaceuticals |
| Website |
www |
| Footnotes / references [1] | |
Pliva d.o.o. is a pharmaceutical company based in Zagreb, Croatia that primarily manufactures and sells generic drugs. It is a subsidiary of Teva Pharmaceuticals.
Pliva is one of the world's largest producers of generic Adderall.[ citation needed]
History
The company was founded in 1921. [1]
A team of Pliva's researchers, Gabrijela Kobrehel, Gorjana Radobolja-Lazarevski and Zrinka Tamburašev led by Dr. Slobodan Đokić, discovered azithromycin in 1980.[ citation needed]
In June 2002, the company acquired Sidmak for $152.9 million. [2]
Also in June 2002, Zeljko Peric, the chief financial officer of the company, resigned. [3]
In May 2004, the company received approval from the Food and Drug Administration to sell trospium chloride. [4]
In June 2005, the company received approval to sell a generic version of erythropoietin in Croatia. [5]
In November 2005, the company received approval from the Food and Drug Administration to sell a generic version of Azithromycin, [6] Citalopram, [7] and Ondansetron. [8]
In October 2006, Barr Pharmaceuticals acquired Pliva. [9]
On December 23, 2008, Barr Pharmaceuticals was acquired by Teva Pharmaceuticals and the company became part of Teva Active Pharmaceutical Ingredients (TAPI). [10]
References
- ^ a b "Company Profile". Pliva.
- ^ "PLIVA announces acquisition of US-based Sidmak" (Press release). Pliva. June 11, 2002.
- ^ "PLIVA announces management changes" (Press release). Pliva. June 27, 2002.
- ^ "PLIVA Announces FDA Approval of SANCTURA" (Press release). Pliva. May 31, 2004.
- ^ "PLIVA Registers generic EPO in Croatia" (Press release). Pliva. June 21, 2005.
- ^ "PLIVA Announces Approval for Azithromycin Tablets" (Press release). Pliva. November 15, 2005.
- ^ "PLIVA Announces Approval for Citalopram Hydrobromide Tablets" (Press release). Pliva. November 3, 2005.
- ^ "PLIVA Announces Approval for Ondansetron Hydrochloride ODT" (Press release). Pliva. November 21, 2005.
- ^ "Barr Acquires PLIVA d.d." (Press release). Pliva. October 12, 2006.
- ^ "TEVA COMPLETES ACQUISITION OF BARR" (Press release). Pliva. December 23, 2008.
